Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1793262

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1793262

Global Peanut Allergy Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

PUBLISHED:
PAGES: 102 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 6375
PDF (Enterprise User License)
USD 8500

Add to Cart

This research report focuses on the Peanut Allergy Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market by Type
    • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Epinephrine Injection
    • 1.2.3 Antihistamines
    • 1.2.4 Oral Immunotherapy
    • 1.2.5 Other
  • 1.3 Market by Distribution Channel
    • 1.3.1 Global Market Share by Distribution Channel: 2020 VS 2024 VS 2031
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Peanut Allergy Therapeutics Market Perspective (2020-2031)
  • 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
  • 2.3 Global Peanut Allergy Therapeutics Revenue Market Share by Region (2020-2025)
  • 2.4 Global Peanut Allergy Therapeutics Revenue Forecast by Region (2026-2031)
  • 2.5 Major Region and Emerging Market Analysis
    • 2.5.1 North America Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.2 Europe Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.3 Asia-Pacific Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.4 Latin America Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.5 Middle East & Africa Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

  • 3.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2020-2025)
  • 3.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2026-2031)
  • 3.3 Different Types Peanut Allergy Therapeutics Representative Players

4 Breakdown Data by Distribution Channel

  • 4.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2020-2025)
  • 4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2026-2031)
  • 4.3 New Sources of Growth in Peanut Allergy Therapeutics Application

5 Competition Landscape by Players

  • 5.1 Global Top Players by Revenue
    • 5.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2020-2025)
    • 5.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2020-2025)
  • 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 5.3 Players Covered: Ranking by Peanut Allergy Therapeutics Revenue
  • 5.4 Global Peanut Allergy Therapeutics Market Concentration Analysis
    • 5.4.1 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 5.4.2 Global Top 10 and Top 5 Companies by Peanut Allergy Therapeutics Revenue in 2024
  • 5.5 Global Key Players of Peanut Allergy Therapeutics Head office and Area Served
  • 5.6 Global Key Players of Peanut Allergy Therapeutics, Product and Application
  • 5.7 Global Key Players of Peanut Allergy Therapeutics, Date of Enter into This Industry
  • 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments and Downstream
    • 6.1.1 North America Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.1.2 North America Market Size by Type
      • 6.1.2.1 North America Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.1.2.2 North America Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.1.3 North America Market Size by Distribution Channel
      • 6.1.3.1 North America Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.1.3.2 North America Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.1.4 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments and Downstream
    • 6.2.1 Europe Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.2.2 Europe Market Size by Type
      • 6.2.2.1 Europe Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.2.2.2 Europe Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.2.3 Europe Market Size by Distribution Channel
      • 6.2.3.1 Europe Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.2.3.2 Europe Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.2.4 Europe Market Trend and Opportunities
  • 6.3 Asia-Pacific Market: Players, Segments and Downstream
    • 6.3.1 Asia-Pacific Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.3.2 Asia-Pacific Market Size by Type
      • 6.3.2.1 Asia-Pacific Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.3.2.2 Asia-Pacific Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.3.3 Asia-Pacific Market Size by Distribution Channel
      • 6.3.3.1 Asia-Pacific Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.3.3.2 Asia-Pacific Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.3.4 Asia-Pacific Market Trend and Opportunities
  • 6.4 Latin America Market: Players, Segments and Downstream
    • 6.4.1 Latin America Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.4.2 Latin America Market Size by Type
      • 6.4.2.1 Latin America Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.4.2.2 Latin America Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.4.3 Latin America Market Size by Distribution Channel
      • 6.4.3.1 Latin America Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.4.3.2 Latin America Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.4.4 Latin America Market Trend and Opportunities
  • 6.5 Middle East & Africa Market: Players, Segments and Downstream
    • 6.5.1 Middle East & Africa Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.5.2 Middle East & Africa Market Size by Type
      • 6.5.2.1 Middle East & Africa Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.5.2.2 Middle East & Africa Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.5.3 Middle East & Africa Market Size by Distribution Channel
      • 6.5.3.1 Middle East & Africa Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.5.3.2 Middle East & Africa Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles

  • 7.1 Viatris
    • 7.1.1 Viatris Company Details
    • 7.1.2 Viatris Business Overview
    • 7.1.3 Viatris Peanut Allergy Therapeutics Introduction
    • 7.1.4 Viatris Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.1.5 Viatris Recent Development
  • 7.2 Bayer
    • 7.2.1 Bayer Company Details
    • 7.2.2 Bayer Business Overview
    • 7.2.3 Bayer Peanut Allergy Therapeutics Introduction
    • 7.2.4 Bayer Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.2.5 Bayer Recent Development
  • 7.3 UCB Pharma
    • 7.3.1 UCB Pharma Company Details
    • 7.3.2 UCB Pharma Business Overview
    • 7.3.3 UCB Pharma Peanut Allergy Therapeutics Introduction
    • 7.3.4 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.3.5 UCB Pharma Recent Development
  • 7.4 J & J
    • 7.4.1 J & J Company Details
    • 7.4.2 J & J Business Overview
    • 7.4.3 J & J Peanut Allergy Therapeutics Introduction
    • 7.4.4 J & J Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.4.5 J & J Recent Development
  • 7.5 Perrigo
    • 7.5.1 Perrigo Company Details
    • 7.5.2 Perrigo Business Overview
    • 7.5.3 Perrigo Peanut Allergy Therapeutics Introduction
    • 7.5.4 Perrigo Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.5.5 Perrigo Recent Development
  • 7.6 GSK
    • 7.6.1 GSK Company Details
    • 7.6.2 GSK Business Overview
    • 7.6.3 GSK Peanut Allergy Therapeutics Introduction
    • 7.6.4 GSK Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.6.5 GSK Recent Development
  • 7.7 Kaleo
    • 7.7.1 Kaleo Company Details
    • 7.7.2 Kaleo Business Overview
    • 7.7.3 Kaleo Peanut Allergy Therapeutics Introduction
    • 7.7.4 Kaleo Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.7.5 Kaleo Recent Development
  • 7.8 Amneal Pharma
    • 7.8.1 Amneal Pharma Company Details
    • 7.8.2 Amneal Pharma Business Overview
    • 7.8.3 Amneal Pharma Peanut Allergy Therapeutics Introduction
    • 7.8.4 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.8.5 Amneal Pharma Recent Development
  • 7.9 ALK Abello
    • 7.9.1 ALK Abello Company Details
    • 7.9.2 ALK Abello Business Overview
    • 7.9.3 ALK Abello Peanut Allergy Therapeutics Introduction
    • 7.9.4 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.9.5 ALK Abello Recent Development
  • 7.10 Aimmune Therapeutics
    • 7.10.1 Aimmune Therapeutics Company Details
    • 7.10.2 Aimmune Therapeutics Business Overview
    • 7.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Introduction
    • 7.10.4 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.10.5 Aimmune Therapeutics Recent Development
  • 7.11 HUAPONT Pharm
    • 7.11.1 HUAPONT Pharm Company Details
    • 7.11.2 HUAPONT Pharm Business Overview
    • 7.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Introduction
    • 7.11.4 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.11.5 HUAPONT Pharm Recent Development
  • 7.12 Allergy Therapeutics
    • 7.12.1 Allergy Therapeutics Company Details
    • 7.12.2 Allergy Therapeutics Business Overview
    • 7.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Introduction
    • 7.12.4 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.12.5 Allergy Therapeutics Recent Development
  • 7.13 ASIT Biotech
    • 7.13.1 ASIT Biotech Company Details
    • 7.13.2 ASIT Biotech Business Overview
    • 7.13.3 ASIT Biotech Peanut Allergy Therapeutics Introduction
    • 7.13.4 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.13.5 ASIT Biotech Recent Development
  • 7.14 Sanofi
    • 7.14.1 Sanofi Company Details
    • 7.14.2 Sanofi Business Overview
    • 7.14.3 Sanofi Peanut Allergy Therapeutics Introduction
    • 7.14.4 Sanofi Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.14.5 Sanofi Recent Development
  • 7.15 DBV Technologies
    • 7.15.1 DBV Technologies Company Details
    • 7.15.2 DBV Technologies Business Overview
    • 7.15.3 DBV Technologies Peanut Allergy Therapeutics Introduction
    • 7.15.4 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.15.5 DBV Technologies Recent Development
  • 7.16 HAL Allergy
    • 7.16.1 HAL Allergy Company Details
    • 7.16.2 HAL Allergy Business Overview
    • 7.16.3 HAL Allergy Peanut Allergy Therapeutics Introduction
    • 7.16.4 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.16.5 HAL Allergy Recent Development
  • 7.17 Intrommune Therapeutics
    • 7.17.1 Intrommune Therapeutics Company Details
    • 7.17.2 Intrommune Therapeutics Business Overview
    • 7.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Introduction
    • 7.17.4 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.17.5 Intrommune Therapeutics Recent Development

8 Peanut Allergy Therapeutics Market Dynamics

  • 8.1 Peanut Allergy Therapeutics Industry Trends
  • 8.2 Peanut Allergy Therapeutics Market Drivers
  • 8.3 Peanut Allergy Therapeutics Market Challenges
  • 8.4 Peanut Allergy Therapeutics Market Restraints

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market by Type
    • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Epinephrine Injection
    • 1.2.3 Antihistamines
    • 1.2.4 Oral Immunotherapy
    • 1.2.5 Other
  • 1.3 Market by Distribution Channel
    • 1.3.1 Global Market Share by Distribution Channel: 2020 VS 2024 VS 2031
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Peanut Allergy Therapeutics Market Perspective (2020-2031)
  • 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
  • 2.3 Global Peanut Allergy Therapeutics Revenue Market Share by Region (2020-2025)
  • 2.4 Global Peanut Allergy Therapeutics Revenue Forecast by Region (2026-2031)
  • 2.5 Major Region and Emerging Market Analysis
    • 2.5.1 North America Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.2 Europe Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.3 Asia-Pacific Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.4 Latin America Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)
    • 2.5.5 Middle East & Africa Peanut Allergy Therapeutics Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

  • 3.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2020-2025)
  • 3.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2026-2031)
  • 3.3 Different Types Peanut Allergy Therapeutics Representative Players

4 Breakdown Data by Distribution Channel

  • 4.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2020-2025)
  • 4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2026-2031)
  • 4.3 New Sources of Growth in Peanut Allergy Therapeutics Application

5 Competition Landscape by Players

  • 5.1 Global Top Players by Revenue
    • 5.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2020-2025)
    • 5.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2020-2025)
  • 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 5.3 Players Covered: Ranking by Peanut Allergy Therapeutics Revenue
  • 5.4 Global Peanut Allergy Therapeutics Market Concentration Analysis
    • 5.4.1 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 5.4.2 Global Top 10 and Top 5 Companies by Peanut Allergy Therapeutics Revenue in 2024
  • 5.5 Global Key Players of Peanut Allergy Therapeutics Head office and Area Served
  • 5.6 Global Key Players of Peanut Allergy Therapeutics, Product and Application
  • 5.7 Global Key Players of Peanut Allergy Therapeutics, Date of Enter into This Industry
  • 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments and Downstream
    • 6.1.1 North America Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.1.2 North America Market Size by Type
      • 6.1.2.1 North America Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.1.2.2 North America Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.1.3 North America Market Size by Distribution Channel
      • 6.1.3.1 North America Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.1.3.2 North America Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.1.4 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments and Downstream
    • 6.2.1 Europe Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.2.2 Europe Market Size by Type
      • 6.2.2.1 Europe Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.2.2.2 Europe Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.2.3 Europe Market Size by Distribution Channel
      • 6.2.3.1 Europe Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.2.3.2 Europe Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.2.4 Europe Market Trend and Opportunities
  • 6.3 Asia-Pacific Market: Players, Segments and Downstream
    • 6.3.1 Asia-Pacific Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.3.2 Asia-Pacific Market Size by Type
      • 6.3.2.1 Asia-Pacific Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.3.2.2 Asia-Pacific Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.3.3 Asia-Pacific Market Size by Distribution Channel
      • 6.3.3.1 Asia-Pacific Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.3.3.2 Asia-Pacific Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.3.4 Asia-Pacific Market Trend and Opportunities
  • 6.4 Latin America Market: Players, Segments and Downstream
    • 6.4.1 Latin America Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.4.2 Latin America Market Size by Type
      • 6.4.2.1 Latin America Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.4.2.2 Latin America Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.4.3 Latin America Market Size by Distribution Channel
      • 6.4.3.1 Latin America Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.4.3.2 Latin America Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.4.4 Latin America Market Trend and Opportunities
  • 6.5 Middle East & Africa Market: Players, Segments and Downstream
    • 6.5.1 Middle East & Africa Peanut Allergy Therapeutics Revenue by Company (2020-2025)
    • 6.5.2 Middle East & Africa Market Size by Type
      • 6.5.2.1 Middle East & Africa Peanut Allergy Therapeutics Market Size by Type (2020-2025)
      • 6.5.2.2 Middle East & Africa Peanut Allergy Therapeutics Market Share by Type (2020-2025)
    • 6.5.3 Middle East & Africa Market Size by Distribution Channel
      • 6.5.3.1 Middle East & Africa Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025)
      • 6.5.3.2 Middle East & Africa Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)
    • 6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles

  • 7.1 Viatris
    • 7.1.1 Viatris Company Details
    • 7.1.2 Viatris Business Overview
    • 7.1.3 Viatris Peanut Allergy Therapeutics Introduction
    • 7.1.4 Viatris Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.1.5 Viatris Recent Development
  • 7.2 Bayer
    • 7.2.1 Bayer Company Details
    • 7.2.2 Bayer Business Overview
    • 7.2.3 Bayer Peanut Allergy Therapeutics Introduction
    • 7.2.4 Bayer Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.2.5 Bayer Recent Development
  • 7.3 UCB Pharma
    • 7.3.1 UCB Pharma Company Details
    • 7.3.2 UCB Pharma Business Overview
    • 7.3.3 UCB Pharma Peanut Allergy Therapeutics Introduction
    • 7.3.4 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.3.5 UCB Pharma Recent Development
  • 7.4 J & J
    • 7.4.1 J & J Company Details
    • 7.4.2 J & J Business Overview
    • 7.4.3 J & J Peanut Allergy Therapeutics Introduction
    • 7.4.4 J & J Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.4.5 J & J Recent Development
  • 7.5 Perrigo
    • 7.5.1 Perrigo Company Details
    • 7.5.2 Perrigo Business Overview
    • 7.5.3 Perrigo Peanut Allergy Therapeutics Introduction
    • 7.5.4 Perrigo Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.5.5 Perrigo Recent Development
  • 7.6 GSK
    • 7.6.1 GSK Company Details
    • 7.6.2 GSK Business Overview
    • 7.6.3 GSK Peanut Allergy Therapeutics Introduction
    • 7.6.4 GSK Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.6.5 GSK Recent Development
  • 7.7 Kaleo
    • 7.7.1 Kaleo Company Details
    • 7.7.2 Kaleo Business Overview
    • 7.7.3 Kaleo Peanut Allergy Therapeutics Introduction
    • 7.7.4 Kaleo Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.7.5 Kaleo Recent Development
  • 7.8 Amneal Pharma
    • 7.8.1 Amneal Pharma Company Details
    • 7.8.2 Amneal Pharma Business Overview
    • 7.8.3 Amneal Pharma Peanut Allergy Therapeutics Introduction
    • 7.8.4 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.8.5 Amneal Pharma Recent Development
  • 7.9 ALK Abello
    • 7.9.1 ALK Abello Company Details
    • 7.9.2 ALK Abello Business Overview
    • 7.9.3 ALK Abello Peanut Allergy Therapeutics Introduction
    • 7.9.4 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.9.5 ALK Abello Recent Development
  • 7.10 Aimmune Therapeutics
    • 7.10.1 Aimmune Therapeutics Company Details
    • 7.10.2 Aimmune Therapeutics Business Overview
    • 7.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Introduction
    • 7.10.4 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.10.5 Aimmune Therapeutics Recent Development
  • 7.11 HUAPONT Pharm
    • 7.11.1 HUAPONT Pharm Company Details
    • 7.11.2 HUAPONT Pharm Business Overview
    • 7.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Introduction
    • 7.11.4 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.11.5 HUAPONT Pharm Recent Development
  • 7.12 Allergy Therapeutics
    • 7.12.1 Allergy Therapeutics Company Details
    • 7.12.2 Allergy Therapeutics Business Overview
    • 7.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Introduction
    • 7.12.4 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.12.5 Allergy Therapeutics Recent Development
  • 7.13 ASIT Biotech
    • 7.13.1 ASIT Biotech Company Details
    • 7.13.2 ASIT Biotech Business Overview
    • 7.13.3 ASIT Biotech Peanut Allergy Therapeutics Introduction
    • 7.13.4 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.13.5 ASIT Biotech Recent Development
  • 7.14 Sanofi
    • 7.14.1 Sanofi Company Details
    • 7.14.2 Sanofi Business Overview
    • 7.14.3 Sanofi Peanut Allergy Therapeutics Introduction
    • 7.14.4 Sanofi Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.14.5 Sanofi Recent Development
  • 7.15 DBV Technologies
    • 7.15.1 DBV Technologies Company Details
    • 7.15.2 DBV Technologies Business Overview
    • 7.15.3 DBV Technologies Peanut Allergy Therapeutics Introduction
    • 7.15.4 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.15.5 DBV Technologies Recent Development
  • 7.16 HAL Allergy
    • 7.16.1 HAL Allergy Company Details
    • 7.16.2 HAL Allergy Business Overview
    • 7.16.3 HAL Allergy Peanut Allergy Therapeutics Introduction
    • 7.16.4 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.16.5 HAL Allergy Recent Development
  • 7.17 Intrommune Therapeutics
    • 7.17.1 Intrommune Therapeutics Company Details
    • 7.17.2 Intrommune Therapeutics Business Overview
    • 7.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Introduction
    • 7.17.4 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)
    • 7.17.5 Intrommune Therapeutics Recent Development

8 Peanut Allergy Therapeutics Market Dynamics

  • 8.1 Peanut Allergy Therapeutics Industry Trends
  • 8.2 Peanut Allergy Therapeutics Market Drivers
  • 8.3 Peanut Allergy Therapeutics Market Challenges
  • 8.4 Peanut Allergy Therapeutics Market Restraints

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

Table 1. Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Peanut Allergy Therapeutics Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Peanut Allergy Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Peanut Allergy Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Peanut Allergy Therapeutics Revenue Share by Region (2020-2025)

Table 6. Global Peanut Allergy Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Peanut Allergy Therapeutics Revenue Share Forecast by Region (2026-2031)

Table 8. Global Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2020-2025)

Table 10. Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 14. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2020-2025)

Table 15. Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2026-2031) & (US$ Million)

Table 16. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2026-2031)

Table 17. New Sources of Growth in Peanut Allergy Therapeutics Application

Table 18. Global Peanut Allergy Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Peanut Allergy Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top Peanut Allergy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Therapeutics as of 2024)

Table 21. Ranking of Global Top Peanut Allergy Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Peanut Allergy Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Peanut Allergy Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Peanut Allergy Therapeutics, Product and Application

Table 25. Global Key Players of Peanut Allergy Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Peanut Allergy Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Peanut Allergy Therapeutics Revenue Market Share by Company (2020-2025)

Table 29. North America Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 31. Europe Peanut Allergy Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Peanut Allergy Therapeutics Revenue Market Share by Company (2020-2025)

Table 33. Europe Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 35. Asia-Pacific Peanut Allergy Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 36. Asia-Pacific Peanut Allergy Therapeutics Revenue Market Share by Company (2020-2025)

Table 37. Asia-Pacific Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 38. Asia-Pacific Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 39. Latin America Peanut Allergy Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 40. Latin America Peanut Allergy Therapeutics Revenue Market Share by Company (2020-2025)

Table 41. Latin America Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 42. Latin America Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 43. Middle East & Africa Peanut Allergy Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 44. Middle East & Africa Peanut Allergy Therapeutics Revenue Market Share by Company (2020-2025)

Table 45. Middle East & Africa Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 47. Viatris Company Details

Table 48. Viatris Business Overview

Table 49. Viatris Peanut Allergy Therapeutics Product

Table 50. Viatris Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Viatris Recent Development

Table 52. Bayer Company Details

Table 53. Bayer Business Overview

Table 54. Bayer Peanut Allergy Therapeutics Product

Table 55. Bayer Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Bayer Recent Development

Table 57. UCB Pharma Company Details

Table 58. UCB Pharma Business Overview

Table 59. UCB Pharma Peanut Allergy Therapeutics Product

Table 60. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 61. UCB Pharma Recent Development

Table 62. J & J Company Details

Table 63. J & J Business Overview

Table 64. J & J Peanut Allergy Therapeutics Product

Table 65. J & J Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 66. J & J Recent Development

Table 67. Perrigo Company Details

Table 68. Perrigo Business Overview

Table 69. Perrigo Peanut Allergy Therapeutics Product

Table 70. Perrigo Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Perrigo Recent Development

Table 72. GSK Company Details

Table 73. GSK Business Overview

Table 74. GSK Peanut Allergy Therapeutics Product

Table 75. GSK Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 76. GSK Recent Development

Table 77. Kaleo Company Details

Table 78. Kaleo Business Overview

Table 79. Kaleo Peanut Allergy Therapeutics Product

Table 80. Kaleo Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Kaleo Recent Development

Table 82. Amneal Pharma Company Details

Table 83. Amneal Pharma Business Overview

Table 84. Amneal Pharma Peanut Allergy Therapeutics Product

Table 85. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Amneal Pharma Recent Development

Table 87. ALK Abello Company Details

Table 88. ALK Abello Business Overview

Table 89. ALK Abello Peanut Allergy Therapeutics Product

Table 90. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 91. ALK Abello Recent Development

Table 92. Aimmune Therapeutics Company Details

Table 93. Aimmune Therapeutics Business Overview

Table 94. Aimmune Therapeutics Peanut Allergy Therapeutics Product

Table 95. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Aimmune Therapeutics Recent Development

Table 97. HUAPONT Pharm Company Details

Table 98. HUAPONT Pharm Business Overview

Table 99. HUAPONT Pharm Peanut Allergy Therapeutics Product

Table 100. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 101. HUAPONT Pharm Recent Development

Table 102. Allergy Therapeutics Company Details

Table 103. Allergy Therapeutics Business Overview

Table 104. Allergy Therapeutics Peanut Allergy Therapeutics Product

Table 105. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 106. Allergy Therapeutics Recent Development

Table 107. ASIT Biotech Company Details

Table 108. ASIT Biotech Business Overview

Table 109. ASIT Biotech Peanut Allergy Therapeutics Product

Table 110. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 111. ASIT Biotech Recent Development

Table 112. Sanofi Company Details

Table 113. Sanofi Business Overview

Table 114. Sanofi Peanut Allergy Therapeutics Product

Table 115. Sanofi Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 116. Sanofi Recent Development

Table 117. DBV Technologies Company Details

Table 118. DBV Technologies Business Overview

Table 119. DBV Technologies Peanut Allergy Therapeutics Product

Table 120. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 121. DBV Technologies Recent Development

Table 122. HAL Allergy Company Details

Table 123. HAL Allergy Business Overview

Table 124. HAL Allergy Peanut Allergy Therapeutics Product

Table 125. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 126. HAL Allergy Recent Development

Table 127. Intrommune Therapeutics Company Details

Table 128. Intrommune Therapeutics Business Overview

Table 129. Intrommune Therapeutics Peanut Allergy Therapeutics Product

Table 130. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

Table 131. Intrommune Therapeutics Recent Development

Table 132. Peanut Allergy Therapeutics Market Trends

Table 133. Peanut Allergy Therapeutics Market Drivers

Table 134. Peanut Allergy Therapeutics Market Challenges

Table 135. Peanut Allergy Therapeutics Market Restraints

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Peanut Allergy Therapeutics Product Picture

Figure 2. Global Peanut Allergy Therapeutics Market Share by Type: 2024 VS 2031

Figure 3. Epinephrine Injection Features

Figure 4. Antihistamines Features

Figure 5. Oral Immunotherapy Features

Figure 6. Other Features

Figure 7. Global Peanut Allergy Therapeutics Market Share by Distribution Channel: 2024 VS 2031

Figure 8. Hospital Pharmacy

Figure 9. Retail Pharmacy

Figure 10. Other

Figure 11. Peanut Allergy Therapeutics Report Years Considered

Figure 12. Global Peanut Allergy Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Peanut Allergy Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Peanut Allergy Therapeutics Revenue Market Share by Region: 2020 VS 2024

Figure 15. North America Peanut Allergy Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Europe Peanut Allergy Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Asia-Pacific Peanut Allergy Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Latin America Peanut Allergy Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Middle East & Africa Peanut Allergy Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Global Peanut Allergy Therapeutics Market Share by Players in 2024

Figure 21. Global Top Peanut Allergy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Therapeutics as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Peanut Allergy Therapeutics Revenue in 2024

Figure 23. North America Peanut Allergy Therapeutics Market Share by Type (2020-2025)

Figure 24. North America Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)

Figure 25. Europe Peanut Allergy Therapeutics Market Share by Type (2020-2025)

Figure 26. Europe Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)

Figure 27. Asia-Pacific Peanut Allergy Therapeutics Market Share by Type (2020-2025)

Figure 28. Asia-Pacific Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)

Figure 29. Latin America Peanut Allergy Therapeutics Market Share by Type (2020-2025)

Figure 30. Latin America Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)

Figure 31. Middle East & Africa Peanut Allergy Therapeutics Market Share by Type (2020-2025)

Figure 32. Middle East & Africa Peanut Allergy Therapeutics Market Share by Distribution Channel (2020-2025)

Figure 33. Viatris Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 34. Bayer Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 35. UCB Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 36. J & J Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 37. Perrigo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 38. GSK Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 39. Kaleo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 40. Amneal Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 41. ALK Abello Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 42. Aimmune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 43. HUAPONT Pharm Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 44. Allergy Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 45. ASIT Biotech Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 46. Sanofi Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 47. DBV Technologies Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 48. HAL Allergy Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 49. Intrommune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!